SEC 13F Intelligence

Managers / Q4 2020 · view latest →

Centerbridge Partners, L.P.

CIK 0001484836 · 375 PARK AVENUE, 11TH FLOOR, NEW YORK, NY, 10152 · 212 672 5000

Reported Value
$1.2B
Q4 2020
Positions
36
Filings on Record
33
2019–present window
Filed
Feb 23, 2021
amendment (RESTATEMENT)

Summary

Centerbridge Partners, L.P. reported $1.2B in U.S.-listed holdings across 36 positions for Q4 2020.

The portfolio is heavily concentrated: Gohealth alone accounts for 46.2% of reported value.

Compared with Q3 2020, the fund opened 8 new positions and exited 1.

Portfolio Metrics

Turnover
+4.4%
vs prior filed quarter
Top-10 Concentration
+97.0%
share of reported value
Largest Position
+46.2%
Gohealth
New / Exited
8 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $982MQ4 ’18Q1 ’19: $729MQ2 ’19: $815MQ3 ’19: $550MQ4 ’19: $618MQ4 ’19Q1 ’20: $412MQ2 ’20: $468MQ3 ’20: $894MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $856MQ4 ’21: $1.8BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.1BQ3 ’22: $875MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.0BQ2 ’23: $642MQ3 ’23: $467MQ4 ’23: $604MQ4 ’23Q1 ’24: $623MQ2 ’24: $505MQ3 ’24: $478MQ4 ’24: $468MQ4 ’24Q1 ’25: $510MQ2 ’25: $434MQ3 ’25: $101MQ4 ’25: $59MQ4 ’25Q1 ’26: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 49.9%Other: 47.7%REIT: 2.3%Unit: 0.1%ADR: 0.1%
  • Common Stock · 49.9% · $588M
  • Other · 47.7% · $561M
  • REIT · 2.3% · $27M
  • Unit · 0.1% · $1M
  • ADR · 0.1% · $965,000

Quarter-over-Quarter Changes full breakdown →

vs Q3 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
RADIUS GLOBAL INFRASTRUCTURE INEW+10.00M10.00M+$129M$129M
ROOT INCNEW+2.29M2.29M+$36M$36M
FEFIRSTENERGY CORPNEW+375.0K375.0K+$11M$11M
EIXEDISON INTLNEW+143.5K143.5K+$9M$9M
DUNE ACQUISITION CORPNEW+500.0K500.0K+$5M$5M
CF ACQUISITION CORP IVNEW+300.0K300.0K+$3M$3M
7GC & CO HOLDINGS INCNEW+185.0K185.0K+$2M$2M
INSU ACQUISITION CORP IIINEW+100.0K100.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2020

18 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GOHEALTH INCCOM CL A46.23%$545M40.68M
2AMERICAN RENAL ASSOCS HLDGSCOM17.12%$202M17.62M
3RADIUS GLOBAL INFRASTRUCTURE ICOM CL A10.91%$129M10.00M
4PCGPG&E CORPhistory →COM7.65%$90M7.23M
5GNKGENCO SHIPPING & TRADING LTDhistory →SHS6.38%$75M10.21M
6ROOT INCCOM CL A3.05%$36M2.29M
7AVBAVALONBAY CMNTYS INChistory →COM2.25%$27M165.4K
8CYHCOMMUNITY HEALTH SYS INC NEWhistory →COM1.64%$19M2.60M
9FEFIRSTENERGY CORPhistory →COM0.97%$11M375.0K
10EIXEDISON INTLCOM0.77%$9M143.5K
11DUNE ACQUISITION CORPUNIT 10/29/20270.44%$5M500.0K
12ENDO INTL PLCSHS0.37%$4M600.0K
13CF ACQUISITION CORP IVUNIT 12/31/20270.26%$3M300.0K
147GC & CO HOLDINGS INCUNIT 12/23/20250.17%$2M185.0K
15EXTENDED STAY AMER INCUNIT 99/99/9999B0.13%$1M100.0K
16REALOGY HLDGS CORPCOM0.11%$1M100.0K
17INSU ACQUISITION CORP IIIUNIT 12/31/20260.09%$1M100.0K
18TEVATEVA PHARMACEUTICAL INDS LTDSPONSORED ADS0.08%$965,000100.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$61M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$59M2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$101M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$434M9Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$510M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$468M13Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$478M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$505M17Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$623M20May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$604M20Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$467M25Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$642M27Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.0B29May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B34Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$875M62Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B67Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.6B71May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.8B111Feb 17, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$856M108Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B124Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B109May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.2B36Feb 23, 2021RESTATEMENTchanges · EDGAR ↗
Q3 2020$894M23Nov 17, 202013F-HRchanges · EDGAR ↗
Q2 2020$468M33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$412M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$618M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$550M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$815M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$729M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$982M37Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 10 additional managers.

  • Centerbridge Credit Advisors, L.L.C.028-13862
  • Centerbridge Partners Holdings, LLC028-13861
  • Aronson Jeffrey028-13858
  • Gallogly Mark T028-13857
  • Centerbridge Special Credit Advisors, L.L.C.028-14395
  • Centerbridge Advisors, LLC028-15424
  • Centerbridge Special Credit Advisors II, L.L.C028-16779
  • Centerbridge Special Credit Advisors III, L.L.C.028-19382
  • Centerbridge Advisors II, LLC028-20085
  • Centerbridge Advisors III, LLC028-21012

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.